TRVI (STOCKS)
Trevi Therapeutics, Inc. Common Stock
$18.150000
+0.420000 (+2.37%)
Prev close: $17.730000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jennifer L. Good
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,584.51M
- Employees
- 33
- P/E (TTM)
- -51.74
- P/B (TTM)
- 7.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Assets | $330.52M |
| Current Assets | $325.71M |
| Prepaid Expenses | $4.26M |
| Other Current Assets | $321.44M |
| Noncurrent Assets | $4.81M |
| Fixed Assets | $336.00K |
| Other Non-current Assets | $4.48M |
| Liabilities | $9.01M |
| Current Liabilities | $8.74M |
| Accounts Payable | $3.10M |
| Other Current Liabilities | $5.64M |
| Noncurrent Liabilities | $276.00K |
| Equity | $321.51M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $321.51M |
| Liabilities And Equity | $330.52M |